Loxo@Lilly aims to create medicines that make life better for all those affected by cancer around the world. Bringing together the focus and spirit of a biotech with the scale, resources, and heritage of Lilly, our team is focused on rapidly delivering impactful new medicines for people with cancer. Our approach centers on creating oncology medicines that unequivocally show early signs of clinical activity and will matter to patients. Loxo@Lilly is a global organization with team members in Boulder, Colorado; Indianapolis, Indiana; New York City, New York; San Diego, California; South San Francisco, California; Stamford, Connecticut; and Madrid, Spain. When you engage with Loxo@Lilly on LinkedIn (and any other of Lilly's social media channels), you are agreeing to these Community Guidelines in addition to the Terms and Conditions or other legal notices provided by Lilly and those of LinkedIn: https://e.lilly/guidelines
Looking for a particular Loxo@Lilly employee's phone or email?
The Loxo@Lilly annual revenue was $16.8 million in 2026.
Narasimha Marella is the Associate Vice President , Clinical Biomarker and Diagnostics Operations of Loxo@Lilly.
159 people are employed at Loxo@Lilly.
Loxo@Lilly is based in Stamford, Connecticut.
The NAICS codes for Loxo@Lilly are [541, 32, 3254, 541711, 325, 54171, 325414, 54, 5417, 32541].
The SIC codes for Loxo@Lilly are [28, 283].